More than a quarter of adults worldwide could benefit from GLP-1 medications for weight loss, study finds

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like diabetes, cardiovascular disease, and cancers. This public health crisis strains global health care systems and economies, but a new study co-led by investigators from Mass General Brigham could inform strategic programs to make GLP-1 medications part of the solution.

Suppressing postoperative inflammation may prolong pain

Taking anti-inflammatory drugs after surgery is fairly standard protocol. But a new study from researchers at Michigan State University suggests this approach may be backfiring and that blocking inflammation during this critical time may, in fact, delay recovery and prolong pain rather than relieve it.